Adaptive Biotechnologies Corp (NASDAQ: ADPT) started the day on Wednesday, with a price decrease of -11.27% at $2.44, before settling in for the price of $2.75 at the close. Taking a more long-term approach, ADPT posted a 52-week range of $2.53-$9.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 27.46%. Meanwhile, its Annual Earning per share during the time was -32.91%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 16.03%. This publicly-traded company’s shares outstanding now amounts to $145.08 million, simultaneously with a float of $138.51 million. The organization now has a market capitalization sitting at $354.02 million. At the time of writing, stock’s 50-day Moving Average stood at $3.42, while the 200-day Moving Average is $4.88.
Adaptive Biotechnologies Corp (ADPT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Adaptive Biotechnologies Corp’s current insider ownership accounts for 4.54%, in contrast to 95.40% institutional ownership. According to the most recent insider trade that took place on Mar 05 ’24, this organization’s CEO and Chairman sold 48,673 shares at the rate of 3.43, making the entire transaction reach 167,007 in total value, affecting insider ownership by 2,576,701. Preceding that transaction, on Mar 05 ’24, Company’s President sold 39,070 for 3.47, making the whole transaction’s value amount to 135,764. This particular insider is now the holder of 472,754 in total.
Adaptive Biotechnologies Corp (ADPT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 7.73 per share during the current fiscal year.
Adaptive Biotechnologies Corp’s EPS increase for this current 12-month fiscal period is 16.03% and is forecasted to reach -1.08 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 21.60% through the next 5 years, which can be compared against the -32.91% growth it accomplished over the previous five years trading on the market.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
Let’s observe the current performance indicators for Adaptive Biotechnologies Corp (ADPT). It’s Quick Ratio in the last reported quarter now stands at 4.50. The Stock has managed to achieve an average true range (ATR) of 0.28. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.08.
In the same vein, ADPT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.56, a figure that is expected to reach -0.35 in the next quarter, and analysts are predicting that it will be -1.08 at the market close of one year from today.
Technical Analysis of Adaptive Biotechnologies Corp (ADPT)
If we take a close look at the recent performances of Adaptive Biotechnologies Corp (NASDAQ: ADPT), its last 5-days Average volume was 3.12 million that shows progress from its year to date volume of 1.59 million. During the previous 9 days, stock’s Stochastic %D was recorded 34.38% While, its Average True Range was 0.29.
Raw Stochastic average of Adaptive Biotechnologies Corp (ADPT) in the period of the previous 100 days is set at 0.33%, which indicates a major fall in contrast to 1.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 122.17% that was higher than 79.18% volatility it exhibited in the past 100-days period.
